Cumberland Pharmaceuticals Inc. Accounts Payable
Cumberland Pharmaceuticals Inc. (CPIX) had Accounts Payable of $19.55 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $19.55M.
- 2026-03-31: Accounts Payable, Current $16.54M.
- 2025-12-31: Accounts Payable, Current $18.57M.
- 2025-09-30: Accounts Payable, Current $13.83M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $19.55M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $16.54M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $18.57M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $13.83M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $13.45M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $13.93M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $13.91M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $12.06M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $12.51M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $13.08M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $14.04M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $10.82M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $10.91M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $11.22M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $10.82M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $11.51M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $10.59M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $11.45M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $9.64M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $9.23M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $8.96M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $10.47M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $13.40M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $10.83M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $10.83M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $8.25M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $9.99M 10-K · filed 2021-03-12 | $11.91M 10-K · filed 2020-03-20 |
| 2019-09-30 | $8.23M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $9.54M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $9.29M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $8.21M 8-K · filed 2020-12-10 | $11.09M 10-K · filed 2019-03-12 |
| 2018-09-30 | $8.45M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $10.07M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $8.52M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $8.98M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $7.92M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $6.41M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $7.27M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $8.04M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $6.66M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $3.67M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $4.07M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $2.88M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $4.13M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.11M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $3.37M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $3.24M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $3.21M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $4.22M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $4.72M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $2.04M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $2.27M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $3.09M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $3.43M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $2.79M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $4.23M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $2.94M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $2.30M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $1.51M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $3.28M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $2.30M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $2.12M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |